Variant report
Variant | nsv979379 |
---|---|
Chromosome Location | chr2:180589246-180596723 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:180584134..180586759-chr2:180588333..180591322,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567474531 | chr2:180591029-180591030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149611528 | chr2:180591030-180591031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74474926 | chr2:180591053-180591054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573216037 | chr2:180591067-180591068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538929522 | chr2:180591073-180591074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199588969 | chr2:180591143-180591144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112165265 | chr2:180591181-180591182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558524496 | chr2:180591213-180591214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555172978 | chr2:180591246-180591247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544308678 | chr2:180591251-180591252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74949558 | chr2:180591271-180591272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369287927 | chr2:180591318-180591319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574175124 | chr2:180591348-180591349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554615409 | chr2:180591370-180591371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540462632 | chr2:180591408-180591409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1964081 | chr2:180591421-180591422 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs532714410 | chr2:180591433-180591434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537766044 | chr2:180591460-180591461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186357066 | chr2:180591493-180591494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376374731 | chr2:180591494-180591495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144361407 | chr2:180591500-180591501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531575144 | chr2:180591555-180591556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112456470 | chr2:180591620-180591621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115878432 | chr2:180591670-180591671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542618765 | chr2:180591698-180591699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189497619 | chr2:180591702-180591703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576831209 | chr2:180591796-180591797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183834918 | chr2:180594826-180594827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549645986 | chr2:180594852-180594853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566232217 | chr2:180594885-180594886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564263833 | chr2:180594886-180594887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73046852 | chr2:180594894-180594895 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs368637612 | chr2:180594938-180594939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149930569 | chr2:180594940-180594941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188113108 | chr2:180594943-180594944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537483871 | chr2:180594988-180594989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557065379 | chr2:180595008-180595009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181995355 | chr2:180595034-180595035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542663935 | chr2:180595040-180595041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540517558 | chr2:180595046-180595047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112603142 | chr2:180595063-180595064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555149461 | chr2:180595065-180595066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562024050 | chr2:180595147-180595148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571871506 | chr2:180595149-180595150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372733977 | chr2:180595150-180595151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145017590 | chr2:180595167-180595168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533060314 | chr2:180595168-180595169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79184043 | chr2:180595300-180595301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16866963 | chr2:180595322-180595323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs186325466 | chr2:180595342-180595343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Schizophrenia | 19348701 | CNVD |
Muscular dystrophy | 17160897 | CNVD |
Cardiomyopathy | 17576883 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:180591000-180591800 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr2:180594800-180595400 | Enhancers | Liver | Liver |